For manufacture & commercialisation of a portfolio of biosimilar drugs in Turkey
Dr Reddys Laboratories and TR-Pharm announced a strategic collaboration agreement involving 3 biosimilar products. A total of three products will be registered and subsequently commercialised as a part of this agreement by TR-Pharm in Turkey. TR-Pharm will also manufacture the drug substance and drug product upon competition of its facility investment.Powered by Capital Market - Live News
